|
|
| (89 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| − | {{tp|p=32362782|t=2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32330209|t=ä. A precision medicine approach to managing 2019 novel coronavirus pneumonia |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| − |
| |
| − |
| |
| − |
| |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32280058|t=ä. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol |pdf=|usr=}}
| |
| − | {{tp|p=32316056|t=2020. Therapie von PatientInnen mit COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32231173|t=2020. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32356672|t=2020. COVID-19 - mehr Lungen-PoCUS und sparsam mit Stethoskop, Thoraxrontgen und Lungen-CT umgehen |pdf=|usr=}}
| |
| − | {{tp|p=32336959|t=2020. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32269081|t=2020. Phylogenetic network analysis of SARS-CoV-2 genomes |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| − | {{tp|p=32165541|t=2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| − |
| |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32304647|t=2020. SARS-CoV-2 shedding and infectivity |pdf=|usr=}}
| |
| − | {{tp|p=32304646|t=ä. SARS-CoV-2 shedding and infectivity ? Authors reply |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 53: |
Zeile 37: |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| − | *'''[[Early symptoms]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]'''
| |
| | | | |
| − | *'''[[Co-Infection]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32356640|t=2020. SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female |pdf=|usr=}}
| |
| − | {{tp|p=32329980|t=2020. SARS-CoV-2 infection masquerading as a possible pulmonary embolism |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Hematology]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32294340|t=ä. Immune Thrombocytopenic Purpura in a Patient with Covid-19 |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32329981|t=2020. Terra incognita: clinically suspected myocarditis in a SARS-CoV-2 positive patient |pdf=|usr=}}
| + | |
| − | {{tp|p=32169400|t=ä. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis? |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| | | | |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]''' | + | *'''[[Hematology]]''' |
| − | {{tp|p=32328338|t=2020. Anal swab findings in an infant with COVID?19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32356641|t=2020. Addressing multiple gastroenterological aspects of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32250094|t=2020. Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| + | *'''[[Heart]]''' |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=32326988|t=ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| | | | |
| − | ----
| + | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
| |
| − | {{tp|p=32329979|t=2020. COVID-19 rapid antibody cassette point of care tests: practical considerations |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[The morbid survivor]]''' |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| − | {{tp|p=32231171|t=2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis |pdf=|usr=}}
| |
| − | {{tp|p=32329978|t=2020. Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[The morbid survivor]]'''
| |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| − | {{tp|p=C7128843|t=ä. A Sever case of of SARS-CoV-2 infection in Gansu |pdf=|usr=}}
| |
| − | {{tp|p=32267140|t=2020. Rapid progression of inflammatory pulmonary infiltrates in severe acute respiratory syndrome coronavirus 2 infection in a young man |pdf=|usr=}}
| |
| − | {{tp|p=32250095|t=2020. Severe course of coronavirus disease 2019 in a middle-aged man without risk factors |pdf=|usr=}}
| |
| − | {{tp|p=32329977|t=2020. Atypical pneumonia diagnosed as COVID-19 by serologic test (patient # -1 in Poland) |pdf=|usr=}}
| |
| − | {{tp|p=32231172|t=2020. A 63-year-old man treated for coronavirus disease 2019 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | *'''[[Case series]]'''
| |
| − | {{tp|p=32149037|t=2020. Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea |pdf=|usr=}}
| |
| − | {{tp|p=32360481|t=2020. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | |
| | + | |
| | + | *'''[[Case series]]''' |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| | + | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32054787|t=2020. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |pdf=|usr=}}
| |
| − | {{tp|p=32253318|t=2020. Effectiveness of convalescent plasma therapy in severe COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32229574|t=2020. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | ----
| + | *'''[[Other routes of infection]]''' |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]''' | + | |
| | + | *'''[[Biophysics of aerosols]]''' |
| | | | |
| | | | |
| − | *'''[[Other routes of infection]]'''
| |
| − | {{tp|p=32291098|t=ä. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Biophysics of aerosols]]'''
| |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32317139|t=2020. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as ?Personal Protective Equipment? for frontline providers exposed in high-risk head and neck and skull base oncology care |pdf=|usr=}}
| + | |
| − | {{tp|p=32363254|t=2020. Effectiveness of Ultraviolet-C Light and a High-Level Disinfection Cabinet for Decontamination of N95 Respirators |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32356639|t=2020. The ethical dimension of prioritization and allocation decisions within the context of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32312919|t=2020. Guidelines for the management of surgical departments in non-uniform hospitals during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32302070|t=2020. The Impact of COVID-19 in Psychiatry |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32272394|t=2020. Hopelessness, helplessness and resilience: The importance of safeguarding our trainees mental wellbeing during the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32302370|t=2020. Perceptions of the adult US population regarding the novel coronavirus outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32298385|t=2020. Mental health problems and social media exposure during COVID-19 outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32369687|t=2020. COVID-19 Pandemic-Induced Panic Disorder |pdf=|usr=}}
| + | |
| − | {{tp|p=32220590|t=ä. Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people? |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 196: |
Zeile 138: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32242087|t=ä. What the stock market tells us about the post-COVID-19 world |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 209: |
Zeile 149: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32312355|t=ä. Report from the COVID-19 Virtual Summit, Disaster Experts Speak Out, March 31, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32170017|t=2020. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32360608|t=ä. Forecasting the timeframe of coronavirus and human cells interaction with reverse engineering |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Failure of executive measures]]'''
| |
| | | | |
| | | | |
| | | | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − | {{tp|p=32272085|t=2020. Economic sanctions and Iran s capacity to respond to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32313308|t=ä. COVID-19 and the policy sciences: initial reactions and perspectives |pdf=|usr=}}
| |
| − | {{tp|p=32221514|t=ä. How behavioural science data helps mitigate the COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32238221|t=ä. Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics |pdf=|usr=}}
| |
| − | {{tp|p=32279686|t=ä. Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32203324|t=ä. COVID-19 and the crisis of national development |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32294342|t=ä. Death from Covid-19 of 23 Health Care Workers in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32334040|t=ä. The fate of house cats during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| Zeile 240: |
Zeile 176: |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32356642|t=2020. Can we predict the severity of COVID-19 with a routine blood test?|pdf=|usr=}}
| + | |
| − | {{tp|p=C7131747|t=ä. Opinion to address a potential personal protective equipment shortage in the global community during the COVID-19 outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32369686|t=2020. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia |pdf=|usr=}}
| + | |
| − | {{tp|p=32313463|t=2020. 2019 novel coronavirus: an emerging global threat |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| Zeile 249: |
Zeile 182: |
| | | | |
| | | | |
| − | *'''[[PrePrint scene''']] | + | |
| − | *[https://prelights.biologists.com/ prelights]
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| + | |
| − | *[biomol.com assays cytokines general spectrum]
| + | |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| + | |
| − | *[codexdna.com dna synthesis]
| + | |
| − | *[eclipsebio.com around rna]
| + | |
| − | *[btbemulsions.com freud adjuvant kit]
| + | |
| − | *[biophysics.com div.]
| + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
